MedTech News
.................... by Andrew Celentano
Brain-on-a-chip technology reveals how sepsis and neurodegenerative diseases damage the brain
In lieu of animal experiments, researchers from the University of Rochester are using state-of-the-art microchips with human tissue to better understand how the brain operates under healthy conditions and is damaged through neurodegenerative diseases or conditions like sepsis.
AI-radar system tracks subtle health changes by assessing patient’s walk
Engineering and health researchers at the University of Waterloo have developed a radar and artificial intelligence (AI) system that can monitor multiple people walking in busy hospitals and long-term care facilities to identify possible health issues.
Remedy Robotics unveils remotely operable endovascular surgical robot
Remedy Robotics announced that it debuted the N1 system, a remotely operable endovascular surgical robotic system.
Vektor Medical wins CE mark for AI-based arrhythmia mapping system
Vektor Medical today announced it received CE mark approval for its vMap artificial intelligence-powered arrhythmia mapping system.
Medtronic launches full U.S. distribution of Neuroguard IEP carotid stent system
Medtronic (NYSE: MDT)+
today announced the full U.S. rollout of the Neuroguard IEP system, a carotid stent and embolic protection device.
Medtronic launches VitalFlow ECMO in Europe
Medtronic (NYSE: MDT)+
announced today that it kicked off the European launch of its VitalFlow one-system ECMO solution.
Antibody discovered that blocks almost all known HIV variants in neutralization assays
An international research team led by the University of Cologne has discovered an antibody that could advance the fight against HIV. The newly identified antibody 04_A06 proved to be particularly effective in laboratory tests. It was able to neutralize 98.5% of more than 300 different HIV strains, making it one of the broadest antibodies against HIV identified.
Drug discovery platform yields optimized compound against SARS-CoV-2 and shows promise against other RNA-based viruses
In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim UF Scripps Institute has identified a potential new drug against the virus that causes COVID-19.